import "server-only";

import type { ProductResearchDetail } from "@/lib/product-research-types";

export const BATCH1B_RESEARCH: Record<string, ProductResearchDetail> = {
  "bpc-157-tb500-blend": {
    shortDescription: [
      "The BPC-157 + TB-500 blend is two research peptides lyophilized into one vial: the gastric pentadecapeptide BPC-157 and the N-terminal acetylated 17-23 fragment sold as TB-500.[1][2] Forum copy calls that pairing a Wolverine peptide stack. The name is branding. It does not create a third chain.",
      "Tetrava Labs lists the blend with its other [research peptides](/) as a Research Use Only reagent. Labs asking where to buy BPC-157 and TB-500 as one documented lot can start here. This page is the lyophilized blend, not a capsule SKU, and it is not for human or veterinary consumption.",
    ],
    otherKnownTitles: [
      "Wolverine blend",
      "Wolverine peptide stack",
      "BPC-157 / TB-500 blend",
      "BPC TB-500",
    ],
    sections: [
      {
        heading: "How BPC-157 and TB-500 are studied as separate molecules",
        paragraphs: [
          "BPC-157 is a synthetic 15-residue peptide drawn from a gastroprotective protein first worked up at the University of Zagreb. Preclinical reviews place it in gastrointestinal mucosal-protection models and in tissue-repair and angiogenesis readouts in animals.[1] That is BPC-157's literature. It is not the TB-500 literature.",
          "TB-500, as sold, is a fragment. Anti-doping chemists synthesized and characterized the N-terminal acetylated 17-23 stretch of thymosin beta-4 and matched it to material labeled TB-500.[2] Full-length thymosin beta-4 is a 43-residue actin-sequestering protein with its own wound-repair and cardioprotection reviews.[3] A lab that treats the fragment as interchangeable with Tβ4 is reading the wrong molecule.",
        ],
      },
      {
        heading: "A Wolverine blend is two sequences, not a new peptide",
        paragraphs: [
          "The vial holds BPC-157 and the TB-500 fragment. Two identities. Two chromatogram peaks. Marketing language does not fuse them into a third peptide.",
        ],
        bullets: [
          "BPC-157 TB-500 capsules are a different format. This catalog page is the lyophilized blend.",
          "BPC-157 TB-500 oral vs injection searches mix dosage folklore with product form. Tetrava does not publish a human route or a capsule protocol for this SKU.",
          "TB-500 in the blend is still the fragment identified in the 2012 characterization paper, not full thymosin beta-4.[2][3]",
        ],
      },
      {
        heading: "The 2012 paper that identified what TB-500 actually is",
        paragraphs: [
          "Esposito and colleagues at the Ghent doping-control lab treated TB-500 as an analytical unknown. They synthesized the N-terminal acetylated 17-23 fragment of thymosin beta-4, then used liquid chromatography-mass spectrometry to show that the fragment accounted for the material sold under that trade name.[2]",
          "The design is a characterization study, not a tissue-repair trial. For a blend COA, that still matters. The TB-500 peak has to match the fragment, not a 43-residue Tβ4 standard pulled from an older review.[2][3]",
        ],
      },
      {
        heading: "TB-500 vs BPC-157: same vial, different papers",
        paragraphs: [
          "TB-500 vs BPC-157 is a literature split, not a ranking. BPC-157 papers cluster around gastric and connective-tissue models.[1] TB-500 papers, when they are actually about the sold material, cluster around that short actin-binding fragment.[2] The longer Tβ4 reviews sit one step removed.[3]",
          "A mechanism-first comparison lives on the [BPC-157 vs TB-500](/blog/bpc-157-vs-tb-500) note. Use that page when the assay question is which single reagent to run. Use this vial when the protocol needs both sequences in one lot.",
        ],
      },
      {
        heading: "BPC-157 TB-500 peptide for sale: what the COA has to show",
        paragraphs: [
          "BPC-157 TB-500 peptide for sale is a paperwork check. One purity percentage on a two-component blend is not enough. The lot [Certificate of Analysis](/coa-library) has to resolve two identities, BPC-157 and the TB-500 fragment, on the same chromatogram.",
          "The FDA listed BPC-157 and the thymosin beta-4 fragment used as TB-500 among bulk substances that may present significant compounding safety risks.[4] That listing is why this SKU stays Research Use Only. A Wolverine peptide stack buy online query that skips the lot match is shopping a label.",
        ],
      },
      {
        heading: "Laboratory handling for a two-component lyophilized blend",
        paragraphs: [
          "The blend ships lyophilized. Store sealed vials at -20°C. Skip repeated freeze-thaw. Reconstitute under sterile technique with the diluent the SOP names, right before use.",
          "Log diluent lot, target concentration, date, and operator in the ELN so the prep still matches the batch [Certificate of Analysis](/coa-library). This is laboratory preparation. It is not a dosing or injection protocol.",
        ],
      },
    ],
    references: [
      {
        id: 1,
        citation:
          "Sikiric P, Seiwerth S, Rucman R, et al. Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract. Curr Pharm Des. 2011;17(16):1612-1632.",
        url: "https://pubmed.ncbi.nlm.nih.gov/21548867/",
      },
      {
        id: 2,
        citation:
          "Esposito S, Deventer K, Goeman J, Van der Eycken J, Van Eenoo P. Synthesis and characterization of the N-terminal acetylated 17-23 fragment of thymosin beta 4 identified in TB-500, a product suspected to possess doping potential. Drug Test Anal. 2012;4(9):733-738.",
        url: "https://doi.org/10.1002/dta.1402",
      },
      {
        id: 3,
        citation:
          "Goldstein AL, Hannappel E, Sosne G, Kleinman HK. Thymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applications. Expert Opin Biol Ther. 2012;12(1):37-51.",
        url: "https://pubmed.ncbi.nlm.nih.gov/22074294/",
      },
      {
        id: 4,
        citation:
          "U.S. Food and Drug Administration. Certain Bulk Drug Substances for Use in Compounding That May Present Significant Safety Risks.",
        url: "https://www.fda.gov/drugs/human-drug-compounding",
      },
    ],
    authorId: "editorial-team",
    updatedAt: "2026-09-12",
  },
  "glow-bpc-157-tb500-ghk-cu": {
    shortDescription: [
      "GLOW peptide is a marketing name for three lyophilized research peptides in one vial: BPC-157, the TB-500 fragment, and GHK-Cu.[1][2][3] The initials were borrowed. They do not name a receptor, a pathway, or a skin outcome.",
      "Tetrava Labs supplies this GLOW blend peptide with its other [research peptides](/) for laboratory research only. Glow peptide where to buy should resolve to a three-peak, lot-linked COA. Research use only. Not for human or veterinary consumption.",
    ],
    otherKnownTitles: [
      "GLOW blend",
      "GLOW peptides",
      "GLOW blend peptide",
      "BPC-157 / TB-500 / GHK-Cu blend",
      "BPC GHK TB",
    ],
    sections: [
      {
        heading: "What GLOW peptide contains, and why the name is not a mechanism",
        paragraphs: [
          "Three molecules. BPC-157 is the Zagreb pentadecapeptide studied in gastrointestinal and tissue-repair models.[1] TB-500 is the N-terminal acetylated 17-23 fragment of thymosin beta-4, not the full 43-residue protein.[2][4] GHK-Cu is the copper-binding tripeptide glycyl-L-histidyl-L-lysine, reviewed against fibroblast gene-expression datasets.[3]",
          "GLOW peptides, as a search phrase, collapse those three literatures into one brand. A protocol still has to pick a readout that belongs to one of them: mucosal or angiogenic signaling, actin-fragment identity, or copper-peptide gene modulation. The blend does not invent a fourth pathway.",
        ],
      },
      {
        heading: "Is GLOW peptide safe? There is no human label",
        paragraphs: [
          "Is GLOW peptide safe has no package-insert answer. This listing is Research Use Only. It is not an approved drug, and it carries no human safety label.",
          "The FDA listed BPC-157 and the thymosin beta-4 fragment sold as TB-500 among bulk substances that may present significant compounding safety risks.[5] GHK-Cu sits in a different paper trail, gene-expression reviews rather than that compounding docket.[3] None of that becomes a consumer glow claim. Preclinical work on the three components does not license a skin-outcome sentence on this page.",
        ],
      },
      {
        heading: "The 2018 GHK-Cu gene-expression review behind the third component",
        paragraphs: [
          "Pickart and Margolina gathered microarray and related gene-expression data on GHK-Cu and mapped the copper tripeptide against collagen, antioxidant, and anti-inflammatory gene sets.[3] That paper is a synthesis of genomic readouts, not a cosmetic trial and not a blend study.",
          'It is the published reason GHK-Cu is the third component people reach for when a two-peptide tissue-repair pair is not the question. The assay still has to name a gene or protein endpoint. "Glow" is not one.',
        ],
      },
      {
        heading: "GLOW blend peptide vs the two-peptide Wolverine vial",
        paragraphs: [
          "The two-peptide [Wolverine blend](/wolverine-bpc-157-tb-500-blend) stops at BPC-157 and the TB-500 fragment. GLOW keeps those two and adds GHK-Cu. Side by side, the variable is the copper tripeptide, not two unrelated products.",
          "The chromatogram is the check. GLOW resolves three peaks. A two-component vial resolves two. If a label says GLOW and the COA does not show GHK-Cu, the name is doing all the work.",
        ],
      },
      {
        heading: "Glow peptide buy online: three identities on one lot",
        paragraphs: [
          "Glow peptide buy online is a documentation query. Confirm BPC-157, the TB-500 fragment, and GHK-Cu on the same lot [Certificate of Analysis](/coa-library). Three names on a carton without three matched peaks is catalog copy.",
          "Glow peptide price is a vendor field. Identity is a chromatogram. The compounding-risk listing on two of the three components is another reason this SKU stays RUO.[5]",
        ],
      },
      {
        heading: "Laboratory handling for a three-component blend",
        paragraphs: [
          "GLOW ships lyophilized. Store sealed vials at -20°C. Avoid repeated freeze-thaw. Reconstitute under sterile technique with the diluent the multi-peptide SOP names, immediately before use.",
          "Record diluent lot, concentration targets, date, and operator so the prep remains auditable against the batch [Certificate of Analysis](/coa-library). Laboratory preparation only. No human handling schedule belongs on this page.",
        ],
      },
    ],
    references: [
      {
        id: 1,
        citation:
          "Sikiric P, Seiwerth S, Rucman R, et al. Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract. Curr Pharm Des. 2011;17(16):1612-1632.",
        url: "https://pubmed.ncbi.nlm.nih.gov/21548867/",
      },
      {
        id: 2,
        citation:
          "Esposito S, Deventer K, Goeman J, Van der Eycken J, Van Eenoo P. Synthesis and characterization of the N-terminal acetylated 17-23 fragment of thymosin beta 4 identified in TB-500, a product suspected to possess doping potential. Drug Test Anal. 2012;4(9):733-738.",
        url: "https://doi.org/10.1002/dta.1402",
      },
      {
        id: 3,
        citation:
          "Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. Int J Mol Sci. 2018;19(7):1987.",
        url: "https://pubmed.ncbi.nlm.nih.gov/29986520/",
      },
      {
        id: 4,
        citation:
          "Goldstein AL, Hannappel E, Sosne G, Kleinman HK. Thymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applications. Expert Opin Biol Ther. 2012;12(1):37-51.",
        url: "https://pubmed.ncbi.nlm.nih.gov/22074294/",
      },
      {
        id: 5,
        citation:
          "U.S. Food and Drug Administration. Certain Bulk Drug Substances for Use in Compounding That May Present Significant Safety Risks.",
        url: "https://www.fda.gov/drugs/human-drug-compounding",
      },
    ],
    authorId: "editorial-team",
    updatedAt: "2026-09-12",
  },
  "melanotan-2-10mg": {
    shortDescription: [
      "Melanotan 2 is a cyclic alpha-MSH analog, a lactam-bridged heptapeptide of the Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2 style.[1] Melanotan 1 is a linear analog of the same hormone family. The two are not interchangeable reagents.",
      "Tetrava Labs lists Melanotan 2 with its [research peptides](/) as a Research Use Only vial. Melanotan 2 for sale on this page is a documented laboratory reagent. It is not an approved tanning product, and it is not for human or veterinary consumption.",
    ],
    otherKnownTitles: ["MT-2", "Melanotan II", "Melanotan-II", "MT-II"],
    sections: [
      {
        heading: "Melanotan 2 is a cyclic alpha-MSH analog",
        paragraphs: [
          "Alpha-MSH is a linear melanocortin peptide. Melanotan 2 shortens that motif and closes a lactam bridge between aspartic acid and lysine, which is why catalogs call it cyclic.[1] The Dorr pilot paper writes the clinic compound as Ac-Nle4-Asp5-His6-D-Phe7-Arg8-Trp9-Lys10-NH2 with that bridge in place.",
          "Research suggests the cyclic constraint is the structural fact that separates Melanotan 2 from linear alpha-MSH analogs. Receptor-subtype rankings belong in a binding assay, not in a consumer comparison. This page does not publish Ki values.",
        ],
      },
      {
        heading: "An unapproved tanning peptide is not a catalog outcome",
        paragraphs: [
          "Melanotan 2 vs 1 traffic often wants a verdict on which analog tans better. That is consumer advice. This listing will not give it. The difference that belongs here is structure: cyclic heptapeptide versus linear analog.",
          "The FDA has warned about unapproved melanotan products.[2] A Research Use Only vial is not an Amazon tan shot, not a compounded cosmetic, and not a substitute for an approved melanocortin drug. Clinical trials have explored melanotan-II in small clinic pilots. Those pilots do not travel with this SKU as a use label.",
        ],
      },
      {
        heading: "The 1996 pilot phase I study of melanotan-II",
        paragraphs: [
          "Dorr, Lines, Levine, and colleagues ran a pilot phase I evaluation of melanotan-II at the University of Arizona.[1] Design: three healthy male volunteers, single-blind, alternating-day saline or melanotan-II, clinic-administered. The paper is a first-in-human tolerability look at the cyclic analog, not a catalog protocol.",
          "Cite that study for what it is. Small n. Alternating-day placebo control. A cyclic melanotropic peptide in a supervised setting. It does not set a laboratory reconstitution recipe, and it does not make this vial a tanning product.[1]",
        ],
      },
      {
        heading: "Melanotan 2 vs 1: cyclic vs linear analog",
        paragraphs: [
          "Melanotan 2 vs 1 is a backbone question. Melanotan 2 is cyclic. Melanotan 1 is linear, a [Nle4, D-Phe7] style analog of alpha-MSH. Same hormone family, different constraint on the chain.",
          "The linear analog is listed separately as [Melanotan 1](/buy-melanotan-1-online). Pick the reagent that matches the structure the method names. Do not swap them because a forum thread treated them as two strengths of the same tan.",
        ],
      },
      {
        heading: "Where to buy Melanotan 2 as a documented research vial",
        paragraphs: [
          "Where to buy Melanotan 2 is a lot-match question. The vial label and the [Certificate of Analysis](/coa-library) have to name the same batch. A purity percentage with no chromatogram is a sentence, not a result.",
          "Melanotan 2 price is a vendor field. It does not settle identity, and it does not override the FDA's unapproved-product warnings.[2] This catalog lists a lyophilized research vial. It does not list a finished injection.",
        ],
      },
      {
        heading: "Laboratory handling for lyophilized Melanotan 2",
        paragraphs: [
          "Melanotan 2 ships lyophilized. Store sealed vials at -20°C. Avoid repeated freeze-thaw. Reconstitute under sterile technique with the diluent the SOP names, right before use.",
          "Log diluent lot, concentration, date, and operator against the batch [Certificate of Analysis](/coa-library). Laboratory preparation only. This page does not publish a tanning schedule or an administration route.",
        ],
      },
    ],
    references: [
      {
        id: 1,
        citation:
          "Dorr RT, Lines R, Levine N, Brooks C, Xiang L, Hruby VJ, Hadley ME. Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study. Life Sci. 1996;58(20):1777-1784.",
        url: "https://pubmed.ncbi.nlm.nih.gov/8637402/",
      },
      {
        id: 2,
        citation:
          "U.S. Food and Drug Administration. Consumer Updates (unapproved melanotan products).",
        url: "https://www.fda.gov/consumers/consumer-updates",
      },
    ],
    authorId: "editorial-team",
    updatedAt: "2026-09-12",
  },
  "mk-677-5mg": {
    shortDescription: [
      "MK-677 is a nonpeptide ghrelin-receptor agonist, published as ibutamoren.[1][5] It is not a SARM. It is not a steroid. Clinical trials have explored oral MK-677 as a growth-hormone secretagogue in older adults, obese men, diet-induced catabolism, and Alzheimer disease.",
      "Tetrava Labs files MK-677 with its [research peptides](/) as a Research Use Only reagent. Buy MK-677 here for documented laboratory work. Not for human or veterinary consumption.",
    ],
    otherKnownTitles: [
      "Ibutamoren",
      "Ibutamoren mesylate",
      "MK0677",
      "MK-0677",
    ],
    sections: [
      {
        heading: "MK-677 is a ghrelin-receptor agonist, not an androgen ligand",
        paragraphs: [
          "MK-677 binds the ghrelin receptor (GHS-R1a) and is taken by mouth in the published trials. Nass and colleagues gave it to healthy older adults in a randomized, double-blind, placebo-controlled year-long study and reported GH and IGF-1 rising toward a youthful range, with a fat-free-mass signal and a drop in insulin sensitivity.[1]",
          "Murphy's group used oral MK-677 in a diet-induced catabolism model and reported a reversal of that nitrogen-loss signal.[3] Svensson treated obese men for two months and recorded higher GH secretion, higher fat-free mass, and higher fasting insulin and glucose.[2] Those papers are endocrine and metabolic designs. They are not androgen-receptor studies.",
        ],
      },
      {
        heading: "Is MK-677 a SARM, a steroid, or a testosterone suppressor?",
        paragraphs: [
          "Is MK-677 a SARM? No. SARMs bind the androgen receptor. MK-677 is a ghrelin-receptor agonist.[5] Is MK-677 a steroid? No. It is a nonpeptide secretagogue.",
        ],
        bullets: [
          "Does MK-677 suppress testosterone is a different question. Nass, Svensson, Murphy, and Sevigny measured GH, IGF-1, body composition, glucose and insulin, or Alzheimer clinical scales.[1][2][3][4] Those trials were not designed to answer testosterone suppression.",
          "Glucose and insulin shifts in Svensson and Nass are the safety-signal literature worth reading before a protocol that already stresses glycemic endpoints.[1][2] They are not a consumer side-effect blog.",
        ],
      },
      {
        heading: "The Alzheimer trial that raised IGF-1 and missed clinical endpoints",
        paragraphs: [
          "Sevigny, Ryan, van Dyck, and colleagues randomized people with Alzheimer disease to MK-677 or placebo and followed clinical progression.[4] IGF-1 moved. The clinical endpoints did not. Neurology published that as no clinical effect on AD progression.",
          "That miss is the contrarian paper in this set. A secretagogue can raise IGF-1 and still fail the scale the trial was built to win. Use Sevigny when a protocol treats IGF-1 as a surrogate. It is a poor surrogate for that disease endpoint.[4]",
        ],
      },
      {
        heading: "Oral MK-677 vs peptide secretagogues in a protocol",
        paragraphs: [
          "MK-677 is oral in the papers above. [Ipamorelin](/buy-ipamorelin-online) is a peptide GHS. Different chemical class, same receptor family. A method that needs a nonpeptide, orally studied ghrelin-receptor agonist is asking for MK-677. A method that needs a hexapeptide GHS is asking for a different vial.",
          "Do not convert a Nass or Svensson clinic regimen into a catalog schedule. Those milligram figures belong to supervised trials. They do not scale this research vial.",
        ],
      },
      {
        heading: "MK-677 for sale: lot paperwork, not a gym claim",
        paragraphs: [
          "MK-677 for sale on this page is the research reagent. Where to buy MK-677 should mean a lot number on the vial that matches the [Certificate of Analysis](/coa-library). A purity claim with no batch trace is advertising.",
          "This catalog lists MK-677 as a Research Use Only item. The published human work is trial material under a protocol. It is not a use label for this SKU.",
        ],
      },
      {
        heading: "Laboratory handling for MK-677",
        paragraphs: [
          "Store sealed vials at the temperature the spec sheet names, typically -20°C for this catalog's lyophilized reagents. Keep the container dry. Prepare working solutions under the SOP, and skip needless freeze-thaw of aliquots.",
          "Record solvent or diluent lot, concentration, date, and operator so the prep still matches the batch [Certificate of Analysis](/coa-library). Laboratory documentation only. This page does not publish a daily milligram chart.",
        ],
      },
    ],
    references: [
      {
        id: 1,
        citation:
          "Nass R, Pezzoli SS, Oliveri MC, et al. Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial. Ann Intern Med. 2008;149(9):601-611.",
        url: "https://pubmed.ncbi.nlm.nih.gov/18981485/",
      },
      {
        id: 2,
        citation:
          "Svensson J, Lonn L, Jansson JO, et al. Two-month treatment of obese subjects with the oral growth hormone (GH) secretagogue MK-677 increases GH secretion, fat-free mass, and energy expenditure. J Clin Endocrinol Metab. 1998;83(2):362-369.",
        url: "https://pubmed.ncbi.nlm.nih.gov/9467542/",
      },
      {
        id: 3,
        citation:
          "Murphy MG, Plunkett LM, Gertz BJ, et al. MK-677, an orally active growth hormone secretagogue, reverses diet-induced catabolism. J Clin Endocrinol Metab. 1998;83(2):320-325.",
        url: "https://pubmed.ncbi.nlm.nih.gov/9467534/",
      },
      {
        id: 4,
        citation:
          "Sevigny JJ, Ryan JM, van Dyck CH, Peng Y, Lines CR, Farlow MR. Growth hormone secretagogue MK-677: no clinical effect on AD progression in a randomized trial. Neurology. 2008;71(21):1702-1708.",
        url: "https://pubmed.ncbi.nlm.nih.gov/19015485/",
      },
      {
        id: 5,
        citation:
          "Sigalos JT, Pastuszak AW. The Safety and Efficacy of Growth Hormone Secretagogues. Sex Med Rev. 2018;6(1):45-53.",
        url: "https://pmc.ncbi.nlm.nih.gov/articles/PMC5632578/",
      },
    ],
    authorId: "editorial-team",
    updatedAt: "2026-09-12",
  },
  "hexarelin-acetate": {
    shortDescription: [
      "Hexarelin is a synthetic hexapeptide growth-hormone secretagogue. Review literature places it at the ghrelin receptor and notes ACTH, cortisol, and prolactin activity that more GH-selective GHS ligands share to a lesser degree.[1]",
      "Tetrava Labs supplies hexarelin acetate as a Research Use Only reagent with its other [research peptides](/). Labs that buy hexarelin online from this page get a lot-linked vial. It is not a steroid, and it is not for human or veterinary consumption.",
    ],
    otherKnownTitles: [
      "Hexarelin acetate",
      "Examorelin",
      "HEX",
      "Hexarelin",
    ],
    sections: [
      {
        heading: "Hexarelin is a hexapeptide growth-hormone secretagogue",
        paragraphs: [
          "Hexarelin is six amino acids. It is a GHRP-class ligand at GHS-R1a, the ghrelin receptor.[1] Research suggests it releases GH, and the same review record shows ACTH, cortisol, and prolactin moving with it. That broader pituitary footprint is the pharmacological fact that shows up when people compare it with cleaner GHS peptides.",
          "Is hexarelin a steroid? No. A hexapeptide is not an androgen scaffold. Classing it with steroids confuses a secretagogue with a hormone backbone it does not have.",
        ],
      },
      {
        heading: "Hexarelin is not a steroid, and it is less selective than ipamorelin",
        paragraphs: [
          "The GHS safety review treats hexarelin as dirtier on ACTH, cortisol, and prolactin than ipamorelin.[1] Ipamorelin is the GH-selective comparison in that literature. Hexarelin is the ligand you pick when the protocol needs that wider pituitary readout, or when a historical GHRP comparator is required.",
          "None of that is a gym ranking. It is receptor-selectivity language from review papers. A catalog vial does not inherit a human hormone schedule from those tables.",
        ],
      },
      {
        heading: "The sleep-lab study in seven healthy volunteers",
        paragraphs: [
          "Frieboes and colleagues brought seven healthy men into a sleep laboratory and gave hexarelin or placebo one week apart.[2] They sampled GH, ACTH, cortisol, and prolactin through the night and scored the sleep EEG.",
          "Hexarelin shortened stage 4 sleep in the first half of the night. GH and prolactin rose through the night. ACTH and cortisol rose in the first half.[1][2] That is a specific human-volunteer design. It is not a training protocol, and it does not set a reconstitution recipe for this reagent.",
        ],
      },
      {
        heading: "Hexarelin vs ipamorelin, sermorelin, and tesamorelin",
        paragraphs: [
          "Hexarelin vs ipamorelin is a selectivity comparison inside the GHS class. Review literature gives [ipamorelin](/buy-ipamorelin-online) the cleaner GH profile and gives hexarelin the ACTH/cortisol/prolactin footprint.[1]",
          "Hexarelin vs tesamorelin and hexarelin vs sermorelin cross classes. Tesamorelin and sermorelin are GHRH-receptor ligands. Hexarelin is a ghrelin-receptor hexapeptide. Same downstream GH conversation, different first receptor. Write the receptor into the method before you pick the vial.",
        ],
      },
      {
        heading: "Buy hexarelin online as a lot-linked reagent",
        paragraphs: [
          "Hexarelin buy traffic should end at a [Certificate of Analysis](/coa-library) whose lot number matches the vial. Sequence identity and HPLC purity for that batch are the spec. A generic purity PDF reused across products is not.",
          "This catalog lists hexarelin acetate as Research Use Only. The Frieboes sleep study and the GHS review describe clinic or volunteer work.[1][2] They do not label this SKU for human use.",
        ],
      },
      {
        heading: "Laboratory handling for hexarelin acetate",
        paragraphs: [
          "Hexarelin ships lyophilized. Store sealed vials at -20°C. Avoid repeated freeze-thaw. Reconstitute under sterile technique with the diluent the SOP names, immediately before use.",
          "Log diluent lot, concentration, date, and operator so the prep still matches the batch [Certificate of Analysis](/coa-library). Laboratory preparation only. No injection protocol belongs on this page.",
        ],
      },
    ],
    references: [
      {
        id: 1,
        citation:
          "Sigalos JT, Pastuszak AW. The Safety and Efficacy of Growth Hormone Secretagogues. Sex Med Rev. 2018;6(1):45-53.",
        url: "https://pmc.ncbi.nlm.nih.gov/articles/PMC5632578/",
      },
      {
        id: 2,
        citation:
          "Frieboes RM, Antonijevic IA, Held K, Murck H, Pollmacher T, Uhr M, Steiger A. Hexarelin decreases slow-wave sleep and stimulates the secretion of GH, ACTH, cortisol and prolactin during sleep in healthy volunteers. Psychoneuroendocrinology. 2004;29(7):851-860.",
        url: "https://pubmed.ncbi.nlm.nih.gov/15177700/",
      },
    ],
    authorId: "editorial-team",
    updatedAt: "2026-09-12",
  },
  "thymosin-alpha-1": {
    shortDescription: [
      "Thymosin alpha-1 is a 28-residue, N-acetylated fragment of prothymosin alpha, first isolated from thymic tissue as the activity that restored immune readouts in thymectomized mice.[1]",
      "Tetrava Labs lists thymosin alpha-1 with its other [research peptides](/) as a lyophilized reagent for laboratory work only. Labs that buy thymosin alpha-1 use it in dendritic-cell, T-cell subset, and innate-immune signaling assays. Research use only. Not for human or veterinary consumption.",
    ],
    otherKnownTitles: [
      "Thymalfasin",
      "Ta1",
      "Zadaxin (branded product, not this SKU)",
      "Thymosin α1",
    ],
    sections: [
      {
        heading: "How thymosin alpha-1 is studied in immune-cell models",
        paragraphs: [
          "King and Tuthill describe thymosin alpha-1 as a peptide with effects across more than one immune-cell subset, not a single-receptor ligand with one tidy readout.[1] In their review, the peptide acts through Toll-like receptors on myeloid and plasmacytoid dendritic cells, which then turn on signaling pathways and immune-related cytokine production.[1]",
          "That is why labs keep it on an immuno-assay bench. A dendritic-cell maturation plate, a T-cell subset panel, or a cytokine multiplex can all sit on the same lot if the identity work is done first. The literature they summarize is a mix of preclinical models and clinical-program write-ups of branded thymalfasin. Those write-ups do not travel with a research vial.",
        ],
      },
      {
        heading: "Zadaxin is not this vial",
        paragraphs: [
          'Searches for "thymosin alpha 1 peptide fda approved" are usually looking for Zadaxin, the branded thymalfasin product that some countries have licensed as an immune biologic.[1] That license, where it exists, belongs to a finished drug with its own manufacturer, label, and supply chain.',
          "Tetrava's listing is a Research Use Only powder. It is not Zadaxin. It is not thymalfasin as a dispensed medicine. An approval story about a branded immune biologic does not make a catalog vial an approved drug in the United States or anywhere else.",
        ],
      },
      {
        heading: "What King and Tuthill actually reviewed",
        paragraphs: [
          "The review walks through immune-modulation data for thymosin alpha-1 after the original thymic isolation work.[1] The mechanism they put in the foreground is dendritic-cell TLR engagement, then downstream cytokine output and changes in immune-cell subsets used in infection and cancer immunology papers.",
          "They treat that body of work as a rationale for studying immune suppression in the lab and in branded-product programs. They do not convert it into a protocol for a research-chemical vial. If a method section in your lab needs a concentration or exposure time, pull it from the primary paper for that assay. Do not borrow a clinical-program schedule.",
        ],
      },
      {
        heading: "Thymosin alpha-1 vs a branded immune biologic",
        paragraphs: [
          "The useful comparison is supply chain, not sequence trivia. Zadaxin is a licensed finished product in some markets. This page is a documented RUO reagent in the [shop](/shop), sold for plate work and animal-model immunology, not as a substitute biologic.",
          "If a protocol needs a thymic-peptide arm next to other immune-modulating reagents, keep the lot identity on the plate map. Do not treat a branded-drug paper as a certificate for the powder you received. Thymosin alpha-1 is not interchangeable with [TB-500](/buy-tb-500-online). They are different thymic fragments.",
        ],
      },
      {
        heading: "Buying thymosin alpha-1 10mg for research",
        paragraphs: [
          'A thymosin alpha-1 peptide buy online is a documentation question before it is a price question. "Thymosin alpha 1 price" searches often want a pharmacy number. This page shows a research SKU, including a 10mg vial, not a formulary product.',
        ],
        bullets: [
          "Lot match: the lot on the vial should match the lot on the [Certificate of Analysis](/coa-library).",
          "Identity plus purity: a percent line with no lot-linked HPLC or MS record is catalog copy.",
          "Framing: the listing should describe a laboratory reagent, not a substitute for Zadaxin.",
          "Storage language: sealed lyophilized storage and how the vial ships should be stated, not implied.",
        ],
      },
      {
        heading: "Laboratory handling and lot documentation",
        paragraphs: [
          "Thymosin alpha-1 ships lyophilized. Store sealed vials at -20 C. Skip repeat freeze-thaw. Reconstitute under sterile technique with the diluent your SOP names, right before the assay.",
          "Log diluent lot, concentration, date, and operator in the ELN so the prep still matches the batch [Certificate of Analysis](/coa-library) when someone audits the run. This page does not publish a human schedule, an injection method, or a clinical reconstitution recipe.",
        ],
      },
    ],
    references: [
      {
        id: 1,
        citation:
          "King R, Tuthill C. Immune modulation with thymosin alpha 1 treatment. Vitam Horm. 2016;102:151-178.",
        url: "https://doi.org/10.1016/bs.vh.2016.04.003",
      },
    ],
    authorId: "editorial-team",
    updatedAt: "2026-09-12",
  },
  "kisspeptin-10": {
    shortDescription: [
      "Kisspeptin-10 is the C-terminal decapeptide of the KISS1 gene product, the short fragment that still binds the kisspeptin receptor KISS1R, also called GPR54.[2]",
      "Tetrava Labs sells kisspeptin-10 as a lyophilized reagent with its other [research peptides](/), for hypothalamic and HPG-axis laboratory work only. Buy kisspeptin-10 here when the assay needs a documented KISS1R ligand, not a clinic product. Research use only. Not for human or veterinary consumption.",
    ],
    otherKnownTitles: [
      "KP-10",
      "Kisspeptin decapeptide",
      "Metastin(45-54)",
      "KISS1 C-terminal fragment",
    ],
    sections: [
      {
        heading: "How kisspeptin-10 acts at KISS1R",
        paragraphs: [
          "Kisspeptin neurons sit in the hypothalamus and hold a gate on GnRH release. The receptor on those circuits is KISS1R (GPR54). Seminara and colleagues showed that loss-of-function GPR54 mutations disrupt puberty and leave the HPG axis quiet, which is how the receptor earned its place as a puberty regulator.[2]",
          "Kisspeptin-10 is the ten-residue C-terminal piece used in a lot of in-vitro receptor work. It is not the same molecule as kisspeptin-54, the longer circulating form that shows up in many human infusion papers. Same receptor family. Different length, different pharmacokinetics. Do not paste kp-54 exposure data onto a kp-10 vial.",
        ],
      },
      {
        heading: "Kisspeptin-10 is not sex-specific, and kp-10 is not kp-54",
        paragraphs: [
          '"Is kisspeptin for men or women" is the wrong split. KISS1R is a hypothalamic receptor in both sexes.[2] The ligand does not become a male product or a female product because a search query added those words.',
          '"Kisspeptin-10 for men" and "does kisspeptin increase estrogen in men" are outcome questions this page will not answer. Tetrava does not claim testosterone or estrogen results for this reagent. Dhillo\'s human work used kisspeptin-54, not the catalog decapeptide, and even that paper is a supervised endocrine study, not a result you can hang on an RUO vial.[1]',
        ],
      },
      {
        heading: "What Dhillo 2005 measured, and what it did not",
        paragraphs: [
          "Dhillo, Chaudhri, Patterson, and colleagues infused kisspeptin-54 in healthy men and reported stimulation of the hypothalamic-pituitary-gonadal axis, with LH as the main gonadotropin signal.[1] That is a kp-54 paper. The catalog item on this page is kisspeptin-10.",
          "The two fragments share a C-terminal receptor-binding stretch. They do not share clearance, exposure, or a published PK package you can swap. Use Dhillo to justify a KISS1R / HPG-axis question. Do not treat it as identity or potency data for the decapeptide in the vial.",
        ],
      },
      {
        heading: "Kisspeptin-10 vs gonadorelin in HPG-axis assays",
        paragraphs: [
          "Kisspeptin-10 and [gonadorelin](/buy-gonadorelin-online) sit on different rungs. Kisspeptin-10 binds KISS1R on GnRH neurons. Gonadorelin is GnRH itself and binds the pituitary GnRH receptor.",
          "A lab that wants an upstream hypothalamic ligand should not substitute a pituitary GnRH analogue and call it the same arm. Write the receptor into the protocol, then pick the vial. Kisspeptin-10 for sale on this page is the KISS1R reagent, not a gonadorelin alias.",
        ],
      },
      {
        heading: "Kisspeptin-10 for sale: what a research buy checks",
        paragraphs: [
          'Buy kisspeptin-10 the same way you buy any short neuropeptide: lot, identity, then price. A listing that leads with "for men" or an estrogen claim is telling you who it thinks the buyer is.',
        ],
        bullets: [
          "Lot match between vial and [Certificate of Analysis](/coa-library).",
          'Identity for the decapeptide, not a generic "kisspeptin" peak.',
          "No kp-54 methods pasted onto a kp-10 label.",
          "RUO framing. No clinic or hormone-outcome copy.",
        ],
      },
      {
        heading: "Laboratory handling and lot documentation",
        paragraphs: [
          "Kisspeptin-10 ships lyophilized. Store sealed vials at -20 C. Avoid repeat freeze-thaw. Reconstitute under sterile technique with the diluent the assay SOP names.",
          "Record diluent lot, concentration, date, and operator against the batch [Certificate of Analysis](/coa-library). This page does not publish a fertility schedule, a sex-specific dose, or an injection method.",
        ],
      },
    ],
    references: [
      {
        id: 1,
        citation:
          "Dhillo WS, Chaudhri OB, Patterson M, et al. Kisspeptin-54 stimulates the hypothalamic-pituitary-gonadal axis in human males. J Clin Endocrinol Metab. 2005;90(12):6609-6615.",
        url: "https://pubmed.ncbi.nlm.nih.gov/15941865/",
      },
      {
        id: 2,
        citation:
          "Seminara SB, Messager S, Chatzidaki EE, et al. The GPR54 gene as a regulator of puberty. N Engl J Med. 2003;349(17):1614-1627.",
        url: "https://pubmed.ncbi.nlm.nih.gov/14573733/",
      },
    ],
    authorId: "editorial-team",
    updatedAt: "2026-09-12",
  },
  "cagrilintide-semaglutide": {
    shortDescription: [
      "The cagrilintide + semaglutide blend is two ligands in one research vial: cagrilintide (AM833), a long-acting amylin analogue, and semaglutide, a GLP-1 receptor agonist.[1]",
      "Tetrava Labs sells this cagrilintide-semaglutide blend as a lyophilized [research peptides](/) reagent for dual-pathway metabolic assays, not as CagriSema and not as a branded pen. Research use only. Not for human or veterinary consumption.",
    ],
    otherKnownTitles: [
      "CagriSema (investigational name, not this SKU)",
      "AM833 + semaglutide",
      "Cagrilintide/semaglutide blend",
      "Cagrilintide-semaglutide research blend",
    ],
    sections: [
      {
        heading: "Two mechanisms, not one dual agonist",
        paragraphs: [
          "Cagrilintide is an amylin analogue. It is not a GLP-1 agonist. Semaglutide is the GLP-1 agonist in the pair.[1] A cagrilintide semaglutide vial therefore asks an amylin-plus-GLP-1 question with two molecules, two receptor families.",
          "That is a different design from a single-chain dual agonist. If the protocol needs amylin-receptor pharmacology next to GLP-1-receptor pharmacology, the blend is a convenience lot. If the protocol needs one molecule that hits GIP and GLP-1, it is the wrong vial.",
        ],
      },
      {
        heading: "Cagrilintide is not a GLP, and the blend is not tirzepatide",
        paragraphs: [
          '"Is cagrilintide a GLP" has a short answer. No. Cagrilintide is an amylin analogue. Semaglutide is the GLP-1 component. Calling the blend "a GLP" erases half the mechanism.',
          '"Is cagrilintide FDA approved" is also no. CagriSema is an investigational Novo combination name, not an approved finished drug, and not this catalog blend. The blend is also not Ozempic. Ozempic is a branded semaglutide product. Two powders in one RUO vial are not a pen, and they are not [tirzepatide](/buy-tirzepatide-online), which is one GIP/GLP-1 molecule.',
        ],
      },
      {
        heading: "The Enebo 2021 phase 1b combination study",
        paragraphs: [
          "Enebo, Berthelsen, Kankam, and colleagues ran a randomised, controlled phase 1b trial of multiple doses of cagrilintide given with semaglutide 2.4 mg, reading safety, tolerability, pharmacokinetics, and pharmacodynamics.[1] That paper is about concomitant administration of two defined clinical-program materials, not about an unlabeled research blend.",
          "Use it to justify a combination-pharmacology question: amylin analogue plus GLP-1 agonist in the same protocol. Do not copy the trial's product, device, or escalation schema onto this SKU. Later CagriSema programs sit outside this page unless a lot-linked paper is in the reference list.",
        ],
      },
      {
        heading: "Cagrilintide vs semaglutide vs tirzepatide",
        paragraphs: [
          "Cagrilintide vs semaglutide is an amylin-receptor question versus a GLP-1-receptor question. The blend holds both ligands. Cagrilintide vs tirzepatide is a worse mix-up: tirzepatide is a single GIP/GLP-1 dual agonist, not an amylin analogue and not a two-vial combination.[1]",
          "Pick the arm from the receptor list. Amylin plus GLP-1: this blend. GLP-1 only: standalone [semaglutide](/buy-semaglutide-online). GIP plus GLP-1 in one chain: [tirzepatide](/buy-tirzepatide-online). Do not treat those three as interchangeable metabolic reagents.",
        ],
      },
      {
        heading: "Buying a cagrilintide-semaglutide blend with a COA",
        paragraphs: [
          'A cagrilintide--semaglutide blend needs two identities on one chromatogram. One purity number for "the vial" is not enough if the method cannot resolve both peaks.',
        ],
        bullets: [
          "Two confirmed identities: cagrilintide and semaglutide on the same lot [Certificate of Analysis](/coa-library).",
          "Lot on the vial matches lot on the PDF.",
          "No CagriSema, Ozempic, or tirzepatide branding on an RUO blend.",
          "No human weight-loss schedule attached to the listing.",
        ],
      },
      {
        heading: "Laboratory handling and lot documentation",
        paragraphs: [
          "The blend ships lyophilized. Store sealed vials at -20 C. Skip repeat freeze-thaw. Reconstitute under sterile technique with the diluent your SOP names.",
          "Because two peptides share the vial, log both identities, the diluent lot, concentration, date, and operator against the batch [Certificate of Analysis](/coa-library). This page does not publish a CagriSema dose chart or an injection method.",
        ],
      },
    ],
    references: [
      {
        id: 1,
        citation:
          "Enebo LB, Berthelsen KK, Kankam M, et al. Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2.4 mg for weight management: a randomised, controlled, phase 1b trial. Lancet. 2021;397(10286):1736-1748.",
        url: "https://pubmed.ncbi.nlm.nih.gov/33894838/",
      },
    ],
    authorId: "editorial-team",
    updatedAt: "2026-09-12",
  },
  "hcg": {
    shortDescription: [
      "HCG peptide is a search label, not a chemistry label. Human chorionic gonadotropin is an alpha/beta heterodimeric glycoprotein hormone, not a short amino-acid chain.[1][2]",
      "Tetrava Labs lists HCG with its [research peptides](/) as a lyophilized glycoprotein-hormone reagent for LHCGR and immunoassay work. Where can I buy HCG online as a documented RUO material? Here, as 5000 IU and 10000 IU research vials, not as a clinic product. Research use only. Not for human or veterinary consumption.",
    ],
    otherKnownTitles: [
      "Human chorionic gonadotropin",
      "hCG",
      "Chorionic gonadotropin",
      "hCG alpha/beta heterodimer",
    ],
    sections: [
      {
        heading: "HCG is a glycoprotein hormone, not a short peptide",
        paragraphs: [
          "Intact HCG is two subunits, alpha and beta, assembled as a glycosylated heterodimer.[1][2] The alpha subunit is shared with other glycoprotein hormones. The beta subunit is what makes the molecule HCG. That is a different object from a 10- or 28-residue research peptide.",
          'Labs use it when the assay is LHCGR (the LH/hCG receptor), subunit identity, or glycoprotein-hormone immunoassays. "HCG peptide for men" is search slang sitting on top of that biochemistry. It does not turn the heterodimer into a short peptide, and it does not make this listing a men\'s-health product.',
        ],
      },
      {
        heading: "The diet-drop mix-up, and why this vial is not that product",
        paragraphs: [
          'HCG diet drops, pellets, and "homeopathic HCG" were marketed as weight-loss products. FDA has said those HCG diet products are illegal.[3] That warning is a regulatory fact about a consumer scam category. It is not a use instruction, and it is not a research finding about the glycoprotein.',
          "Tetrava does not sell a diet drop. This page is a laboratory glycoprotein-hormone reagent. It is also not interchangeable with [HGH 191aa](/buy-hgh-191aa-online). Those are different hormones, different receptors, different assays.",
        ],
      },
      {
        heading: "What Stenman's review actually covers",
        paragraphs: [
          "Stenman, Alfthan, and Hotakainen reviewed HCG as a glycoprotein used in analytical chemistry, with intact hormone versus free-beta and other forms treated as distinct species.[1] The paper is about what the molecule is and how assays tell those forms apart, including in tumor-marker work.",
          'That is the useful lab takeaway. If your method needs intact heterodimer, say so on the plate map and check the COA against that identity. A "peptide" label in a search box does not tell you which form arrived.',
        ],
      },
      {
        heading: "HCG vs HGH: different hormones",
        paragraphs: [
          "HCG binds the LH/hCG receptor. [HGH 191aa](/buy-hgh-191aa-online) is somatropin and binds the growth-hormone receptor. Filing both under a store GH-axis aisle is merchandising. It is not pharmacology.",
          "Do not swap them in a protocol. Do not treat IU on an HCG vial as a conversion into an HGH amount. This page will not do that arithmetic.",
        ],
      },
      {
        heading: "Where to buy HCG 5000 IU or 10000 IU for research",
        paragraphs: [
          "HCG peptide for sale on this catalog means buy HCG 5000 IU online or buy HCG 10000 IU online as labeled research strengths. Those are vial listings, not a clinic menu and not a diet kit.",
        ],
        bullets: [
          "Lot on the vial matches the [Certificate of Analysis](/coa-library).",
          'Identity language should say glycoprotein hormone / heterodimer, not "short peptide."',
          "No diet-drop, pharmacy-fulfillment, or insurance framing.",
          "No IU-to-milligram conversion table presented as a use guide.",
        ],
      },
      {
        heading: "Laboratory handling and lot documentation",
        paragraphs: [
          "HCG ships lyophilized. Store sealed vials at -20 C. Avoid repeat freeze-thaw. Reconstitute under sterile technique with the diluent your SOP names.",
          "Log strength (5000 IU or 10000 IU as labeled), diluent lot, date, and operator against the batch [Certificate of Analysis](/coa-library). This page does not publish clinic protocols, diet instructions, or an injection method.",
        ],
      },
    ],
    references: [
      {
        id: 1,
        citation:
          "Stenman UH, Alfthan H, Hotakainen K. Human chorionic gonadotropin in cancer. Clin Biochem. 2004;37(7):549-561.",
        url: "https://pubmed.ncbi.nlm.nih.gov/15234236/",
      },
      {
        id: 2,
        citation:
          "National Center for Biotechnology Information. PubChem Compound Summary for human chorionic gonadotropin.",
        url: "https://pubchem.ncbi.nlm.nih.gov/compound/human-chorionic-gonadotropin",
      },
      {
        id: 3,
        citation:
          "U.S. Food and Drug Administration. Avoid Dangerous HCG Diet Products.",
        url: "https://www.fda.gov/consumers/consumer-updates/hcg-diet-products-are-illegal",
      },
    ],
    authorId: "editorial-team",
    updatedAt: "2026-09-12",
  },
  "aicar-50mg": {
    shortDescription: [
      "AICAR peptide is catalog slang for acadesine, 5-aminoimidazole-4-carboxamide ribonucleoside, a nucleoside analogue that cells convert to ZMP, an AMP mimetic that activates AMPK.[1]",
      "Tetrava Labs lists AICAR 50mg with its [research peptides](/) as a lyophilized metabolic reagent for AMPK assays. Buy AICAR here when the protocol needs a documented nucleoside AMPK activator, not a peptide chain. Research use only. Not for human or veterinary consumption.",
    ],
    otherKnownTitles: [
      "Acadesine",
      "AICA-riboside",
      "5-aminoimidazole-4-carboxamide ribonucleoside",
      "ZMP precursor",
    ],
    sections: [
      {
        heading: "How AICAR becomes ZMP and turns on AMPK",
        paragraphs: [
          "Corton, Gillespie, Hawley, and Hardie established AICAR as a practical way to activate AMP-activated protein kinase in intact cells.[1] The nucleoside is taken up and phosphorylated to ZMP. ZMP mimics AMP at AMPK, so the kinase turns on without the cell having to drain ATP first.",
          'That is a pharmacological AMPK switch, useful in glucose-uptake, fatty-acid oxidation, and energy-sensing plates. It is not an amino-acid peptide mechanism. If the notebook says "peptide," the identity section should still say nucleoside analogue.',
        ],
      },
      {
        heading: "AICAR is not a peptide, and a WADA listing is not a performance claim",
        paragraphs: [
          "Peptide catalogs sell AICAR because metabolic labs order it next to actual peptides. The molecule is still acadesine. Calling it an AICAR peptide does not give it a residue sequence.",
          "WADA lists AMPK agonists, including AICAR, on the Prohibited List.[2] That is a doping-control classification. It is not evidence that the reagent improves performance, and this page does not treat the listing as a use claim.",
        ],
      },
      {
        heading: "The Corton 1995 AMPK-activation paper",
        paragraphs: [
          'The Hardie-lab paper is the method reference most AMPK groups still mean when they say they "used AICAR."[1] They showed that AICAR raises the AMPK-activating nucleotide in intact cells and turns the kinase on with a defined chemical handle.',
          "Use that paper to set why AICAR is in the well. Do not turn a cell-method concentration into a body protocol. The 1995 work is an intact-cell biochemistry method, not a human study.",
        ],
      },
      {
        heading: "AICAR vs MOTS-c",
        paragraphs: [
          "AICAR vs MOTS-c shows up in the same metabolic keyword cluster. They are not the same molecule. AICAR is a nucleoside analogue that becomes ZMP and activates AMPK directly.[1] [MOTS-c](/buy-mots-c-online) is a 16-amino-acid peptide encoded in mitochondrial DNA.",
          "A lab can run them as parallel metabolic arms. It cannot treat one COA as a substitute for the other. Different structures, different identity tests, different stock solutions.",
        ],
      },
      {
        heading: "Buying AICAR 50mg for research",
        paragraphs: [
          "AICAR for sale on this page is the 50mg research vial. Buy AICAR when the AMPK method needs a lot-linked nucleoside, not a nameless powder with a peptide story attached.",
        ],
        bullets: [
          "Lot match between vial and [Certificate of Analysis](/coa-library).",
          "Identity as AICAR / acadesine, not as a peptide sequence.",
          "No performance or training copy attached to the WADA listing.",
          "Strength on the label matches the 50mg catalog listing you ordered.",
        ],
      },
      {
        heading: "Laboratory handling and lot documentation",
        paragraphs: [
          "AICAR 50mg ships lyophilized. Store sealed vials at -20 C. Avoid repeat freeze-thaw. Reconstitute under sterile technique with the diluent the AMPK SOP names.",
          "Log diluent lot, concentration, date, and operator against the batch [Certificate of Analysis](/coa-library). This page does not publish a training protocol, a doping schedule, or an injection method.",
        ],
      },
    ],
    references: [
      {
        id: 1,
        citation:
          "Corton JM, Gillespie JG, Hawley SA, Hardie DG. 5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMPK in intact cells. Eur J Biochem. 1995;229(2):558-565.",
        url: "https://pubmed.ncbi.nlm.nih.gov/7737161/",
      },
      {
        id: 2,
        citation: "World Anti-Doping Agency. The Prohibited List.",
        url: "https://www.wada-ama.org/en/prohibited-list",
      },
    ],
    authorId: "editorial-team",
    updatedAt: "2026-09-12",
  },
};
